Correlation of elevated plasma levels of two structurally related growth factors, heparin affin regulatory peptide and midkine, in advanced solid tumor patients

Cancer Detection and Prevention

Volumn 28, Issue 5, 2004, Pages 319-324

  Soulié, Patrick ^a,b   Héroult, Mélanie ^a   Bernard Pierrot, Isabelle ^a   Caruelle, Danièle ^a   Oglobine, Jean ^b   Barritault, Denis ^a   Courty, José ^a  

^a Univ Paris XII Val Marne FRE C ^*  (France)

^b CENTRE RENÉ HUGUENIN   (France)

Author keywords

Angiogenesis; Anticancer treatment; HARP; Midkine; Plasma; Pleiotrophin; Solid tumors

Indexed keywords

CARRIER PROTEIN; CYTOKINE; GROWTH PROMOTOR; MIDKINE; PLEIOTROPHIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MIDDLE AGED; NEOPLASM; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GROWTH SUBSTANCES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 8144221923     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdp.2004.03.004     Document Type: Article

References (29)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 82:1990;4-6
2. Muramatsu T. Midkine (MK), the product of a retinoic acid responsive gene. Int J Dev Biol. 37:1993;183-188
3. Vanderwinden J.M., Mailleux P., Schiffmann S.N., et al. Cellular distribution of the new growth factor pleiotrophin (HB-GAM) mRNA in developing and adult rat tissues. Anat Embryol (Berl). 186:1992;387-406
4. Courty J, Milhiet PE, Delbe J, et al. In: Bikfalvi A, editor. Encyclopedic reference of vascular biology and pathology. Springer; 2000. p. 145-52.
5. Bohlen P., Kovesdi I. HBNF and MK, members of a novel gene family of heparin-binding proteins with potential roles in embryogenesis and brain function. Prog Growth Factor Res. 3:1991;143-157
6. Tsutsui J., Uehara K., Kadomatsu K., et al. A new family of heparin-binding factors: strong conservation of midkine (MK) sequences between the human and the mouse. Biochem Biophys Res Commun. 176:1991;792-797
7. Fang W., Hartmann N., Chow D.T., et al. Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. J Biol Chem. 267:1992;25889-25897
8. Laaroubi K., Delbe J., Vacherot F., et al. Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide. Growth Factors. 10:1994;89-98
9. Zhang N., Deuel T.F. Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors. Curr Opin Hematol. 6:1999;44-50
10. Kurtz A., Schulte A.M., Wellstein A. Pleiotrophin and midkine in normal development and tumor biology. Crit Rev Oncol. 6:1995;151-177
11. O'Brien T., Cranston D., Fuggle S. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res. 56:1996;2515-2518
12. Garver R.I. Jr., Radford D.M., Donis-Keller H., et al. Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer. 74:1994;1584-1590
13. Garver R.I. Jr., Chan C.S., Milner P.G. Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues. Am J Respir Cell Mol Biol. 9:1993;463-466
14. Nakagawara A., Milbrandt J., Muramatsu T., et al. Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res. 55:1995;1792-1797
15. Nakanishi T., Kadomatsu K., Okamoto T., et al. Expression of midkine and pleiotropin in ovarian tumors. Obstet Gynecol. 90:1997;285-290
16. Choudhuri R., Zhang H.T., Donnini S., et al. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res. 57:1997;1814-1819
17. Czubayko F., Schulte A.M., Berchem G.J., et al. Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin. Proc Natl Acad Sci USA. 93:1996;14753-14758
18. Kojima S., Inui T., Kimura T., et al. Synthetic peptides derived from midkine enhance plasminogen activator activity in bovine aortic endothelial cells. Biochem Biophys Res Commun. 206:1995;468-473
19. Ikematsu S., Yano A., Aridome K., et al. Serum midkine levels are increased in patients with various types of carcinomas. Br J Cancer. 83:2000;701-706
20. Souttou B., Juhl H., Hackenbruck J., et al. Relationship between serum concentrations of the growth factor pleiotrophin and pleiotrophin-positive tumors. J Natl Cancer Inst. 90:1998;1468-1473
21. Muramatsu H., Song X.J., Koide N., et al. Enzyme-linked immunoassay for midkine, and its application to evaluation of midkine levels in developing mouse brain and sera from patients with hepatocellular carcinomas. J Biochem (Tokyo). 119:1996;1171-1175
22. Soulié P., Héroult M., Bernard I., et al. Immunoassay for measuring the heparin-binding growth factors HARP and MK in biological fluids. J. Immunoassay. 23:2002;33-48
23. Najjam S., Gibbs R.V., Gordon M.Y., et al. Characterization of human recombinant interleukin 2 binding to heparin and heparan sulfate using an ELISA approach. Cytokine. 9:1997;1013-1022
24. Banks R.E., Forbes M.A., Kinsey S.E., et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer. 77:1998;956-964
25. Okada F., Yamaguchi K., Ichihara A., et al. Purification and structural analysis of a latent form of transforming growth factor-beta from rat platelets. J Biochem (Tokyo). 106:1989;304-310
26. Vacherot F., Caruelle D., Chopin D., et al. Involvement of heparin affin regulatory peptide in human prostate cancer. Prostate. 38:1999;126-136
27. Vacherot F., Delbe J., Heroult M., et al. Glycosaminoglycans differentially bind HARP and modulate its biological activity. J Biol Chem. 274:1999;7741-7747
28. Bohlen P., Muller T., Gautschi-Sova P., et al. Isolation from bovine brain and structural characterization of HBNF, a heparin-binding neurotrophic factor. Growth Factors. 4:1991;97-107
29. Bernard-Pierrot I., Delbe J., Caruelle D., et al. The lysine-rich C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities. J Biol Chem. 276:2001;12228-12234